S&P Pharmaceutical Sector: A Prescription for Growth● The S&P Pharmaceutical sector has great potential for growth.
● The weekly chart shows that after breaking out of the Symmetrical Triangle Pattern, the ETF had a short period of consolidation and is now ready for a rise.
● The daily chart also indicates a Cup & Handle Pattern, with the price trending upward post-breakout.
As the industry revives, certain stocks are ready to achieve similar success
Key stocks to watch:
Hims & Hers NYSE:HIMS
● The price has broken the trendline resistance with high volume.
● More upward movement is likely to follow.
Crinetics Pharmaceuticals NASDAQ:CRNX
● Mirrors HIMS' chart pattern.
● Poised for robust growth after breakout.
XPH
ETFs potential BUYS -XPH-EIDO-EUO-XBI-BIBFor Monday’s open, 5 ETF's are potential buys under my rules for Pullback Strategy. This strategy identifies oversold ETFs and takes advantage of the tendency for prices to revert to the mean in the short term.
The ETFs set up as potential buys for Monday are listed in the table below:
XPH -SPDR S&P Pharmaceuticals
EIDO - Indonesia Invstble Mkt Idx MSCI
EUO - Ultrashort Euro Proshares
XBI - SPDR S&P Biotech
BIB - Ultra Nasdaq Biotechnology Prosh